Compare AU
Compare DRUG vs. QLTY
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare Currency Hedged ETF (DRUG) and the BetaShares Global Quality Leaders ETF (QLTY). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | QLTY | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 61 | 95 |
Median incremental investment | $920.50 | $1,254.45 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,892.10 | $5,108.53 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | QLTY | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | QLTY.AX was created on 2018-11-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. QLTY.AX aims to track an index (before fees and expenses) that comprises 150 global companies (ex-Australia) ranked by highest quality score |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | ADOBE INC (2.38 %) ACCENTURE PLC (2.22 %) INTUIT INC (2.16 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Other (33.29 %) Information Technology (28.66 %) Industrials (9.15 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (67.42 %) Japan (10.43 %) Switzerland (4.55 %) |
Management fee | 0.57 % | 0.35 % |
Key Summary
DRUG | QLTY | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | iSTOXX MUTB Global ex-Australia Quality Leaders Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.35 % |
Price | $7.95 | $31.70 |
Size | $185.172 million | $699.958 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 2.61 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 07/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | QLTY | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 61 | 95 |
Median incremental investment | $920.50 | $1,254.45 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,892.10 | $5,108.53 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | QLTY | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | QLTY |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |